FDA advisers back Medtronic deep brain stimulator for Parkinson's symptoms
This article was originally published in Clinica
Executive Summary
An advisory panel to the US FDA has recommended that Medtronic's Activa deep brain stimulator system be approved for treating the symptoms of Parkinson's disease. The device has been on the market in the US for three years and elsewhere in the world for at least two, for treating essential tremor but US FDA advisers on March 31 still argued at length whether they should give their backing to expanded use of the technology.